ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium

C21H22N5O2S+ — CID 135751759

IUPACethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium
SMILESCC[NH+](Cc1nc2ccccc2c(=O)[nH]1)Cn1nc(-c2ccc(C)cc2)oc1=S
InChIInChI=1S/C21H21N5O2S/c1-3-25(12-18-22-17-7-5-4-6-16(17)19(27)23-18)13-26-21(29)28-20(24-26)15-10-8-14(2)9-11-15/h4-11H,3,12-13H2,1-2H3,(H,22,23,27)/p+1
InChIKeyOKVPZMKURUBLEJ-UHFFFAOYSA-O
MW408.51 g/mol
LogP2.48
Rot. Bonds6

About ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium

ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium (PubChem CID 135751759) has the molecular formula C21H22N5O2S+ and a molecular weight of 408.51 g/mol. Its IUPAC name is ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium.

Molecular Properties

Compound Nameethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium
PubChem CID135751759
Molecular FormulaC21H22N5O2S+
Molecular Weight408.51 g/mol
Exact Mass408.15
IUPAC Nameethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium
SMILESCC[NH+](Cc1nc2ccccc2c(=O)[nH]1)Cn1nc(-c2ccc(C)cc2)oc1=S
InChIInChI=1S/C21H21N5O2S/c1-3-25(12-18-22-17-7-5-4-6-16(17)19(27)23-18)13-26-21(29)28-20(24-26)15-10-8-14(2)9-11-15/h4-11H,3,12-13H2,1-2H3,(H,22,23,27)/p+1
InChIKeyOKVPZMKURUBLEJ-UHFFFAOYSA-O
XLogP2.48
TPSA81.15 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500408.51
LogP ≤ 52.48
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium?
The IUPAC name of ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium (CID 135751759) is ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium.
What is the SMILES notation for ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium?
The canonical SMILES for ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium is CC[NH+](Cc1nc2ccccc2c(=O)[nH]1)Cn1nc(-c2ccc(C)cc2)oc1=S.
What is the InChIKey of ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium?
The InChIKey is OKVPZMKURUBLEJ-UHFFFAOYSA-O. The full InChI is InChI=1S/C21H21N5O2S/c1-3-25(12-18-22-17-7-5-4-6-16(17)19(27)23-18)13-26-21(29)28-20(24-26)15-10-8-14(2)9-11-15/h4-11H,3,12-13H2,1-2H3,(H,22,23,27)/p+1.
What are the key properties of ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium?
ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium has a molecular weight of 408.51 g/mol, XLogP of 2.48, 6 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl-[[5-(4-methylphenyl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]-[(4-oxo-3H-quinazolin-2-yl)methyl]azanium is sourced from PubChem (CID 135751759), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).